NCOA2 and prostate cancer: One of the findings we were able to retrieve using the integrative approach is the nuclear receptor coactivator  NCOA2 that was previously shown to alter AR pathway in primary prostate tumors providing mechanism for its potential role as a prostate cancer oncogene [19].